Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An International Multicentre Randomized Controlled Trial of Intensive Insulin Therapy Targeting Normoglycemia In Acute Myocardial Infarction: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) Pilot Study.

Trial Profile

An International Multicentre Randomized Controlled Trial of Intensive Insulin Therapy Targeting Normoglycemia In Acute Myocardial Infarction: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) Pilot Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 Dec 2018

At a glance

  • Drugs Insulin glargine; Insulin glulisine
  • Indications Hyperglycaemia; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms RECREATE
  • Most Recent Events

    • 15 Jun 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
    • 15 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Feb 2010 New source identified and integrated (Clinical Trials Registry - India record).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top